{"entity":"johnson-johnson","id":"ent_johnson-johnson","name":"Johnson & Johnson","wikidata":"Q333718","page":"https://asof.is/record/johnson-johnson","summary":"Johnson & Johnson is an U.S. multinational manufacturer of pharmaceuticals and medical devices, headquartered in New Brunswick. It reported revenue of $94.19B for the period ended December 28, 2025.","title":"Johnson & Johnson: revenue $94.19B","key_facts":[{"label":"Headquarters","value":"New Brunswick","claim":"clm_5D9D7F332E94"},{"label":"Revenue","value":"$94.19B","recorded":"94,193,000,000 United States dollar","note":"to 2025-12-28","claim":"clm_249E6427F083"},{"label":"Ticker","value":"JNJ · NYSE","claim":"clm_AC3F2B6AB463"}],"faq":[{"question":"Where is Johnson & Johnson headquartered?","answer":"New Brunswick."},{"question":"What is Johnson & Johnson's revenue?","answer":"$94.19B for the period ended December 28, 2025."}],"as_of":"2026-11-08","known_by":null,"since":null,"fact_pages":[{"predicate":"headquarters","page":"https://asof.is/record/johnson-johnson/headquarters","md":"https://asof.is/record/johnson-johnson/headquarters.md","json":"https://asof.is/v1/entities/johnson-johnson/headquarters"},{"predicate":"revenue","page":"https://asof.is/record/johnson-johnson/revenue","md":"https://asof.is/record/johnson-johnson/revenue.md","json":"https://asof.is/v1/entities/johnson-johnson/revenue"},{"predicate":"net_income","page":"https://asof.is/record/johnson-johnson/net_income","md":"https://asof.is/record/johnson-johnson/net_income.md","json":"https://asof.is/v1/entities/johnson-johnson/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/johnson-johnson/operating_income","md":"https://asof.is/record/johnson-johnson/operating_income.md","json":"https://asof.is/v1/entities/johnson-johnson/operating_income"},{"predicate":"quarterly_revenue","page":"https://asof.is/record/johnson-johnson/quarterly_revenue","md":"https://asof.is/record/johnson-johnson/quarterly_revenue.md","json":"https://asof.is/v1/entities/johnson-johnson/quarterly_revenue"}],"products":[],"coverage":{"entity":"johnson-johnson","name":"Johnson & Johnson","kind":"organization","sources":[{"source":"wikidata","item":"Q333718","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":200406,"ticker":"JNJ","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":435,"open":21,"retracted":0,"first":"1886-01-01","predicates":{"cash_and_equivalents":{"claims":76,"open":1,"kind":"fact"},"quarterly_revenue":{"claims":36,"open":1,"kind":"fact"},"total_equity":{"claims":73,"open":1,"kind":"fact"},"shares_outstanding":{"claims":70,"open":1,"kind":"fact"},"total_assets":{"claims":71,"open":1,"kind":"fact"},"net_income":{"claims":16,"open":1,"kind":"fact"},"cik":{"claims":1,"open":1,"kind":"identifier"},"quarterly_net_income":{"claims":46,"open":1,"kind":"fact"},"operating_income":{"claims":6,"open":1,"kind":"fact"},"quarterly_operating_income":{"claims":15,"open":1,"kind":"fact"},"revenue":{"claims":10,"open":1,"kind":"fact"},"x_username":{"claims":1,"open":1,"kind":"identifier"},"registrant_name":{"claims":2,"open":1,"kind":"fact"},"research_and_development":{"claims":5,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":433,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":2,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_B2E80FDC373C","predicate":"cash_and_equivalents","value":"16,910,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 16,910,000,000 United States dollar\", as of 2026-09-27. Claim clm_B2E80FDC373C, https://asof.is/claim/clm_B2E80FDC373C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_B2E80FDC373C","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_0AE18A6EB213","predicate":"cik","value":"0000200406","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cik: 0000200406\", undated. Claim clm_0AE18A6EB213, https://asof.is/claim/clm_0AE18A6EB213, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_0AE18A6EB213","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_5254AF4AFDB0","predicate":"fiscal_year_end","value":"01-03","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson fiscal year end: 01-03\", undated. Claim clm_5254AF4AFDB0, https://asof.is/claim/clm_5254AF4AFDB0, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5254AF4AFDB0","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_5D9D7F332E94","predicate":"headquarters","value":"New Brunswick","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson headquarters: New Brunswick\", undated. Claim clm_5D9D7F332E94, https://asof.is/claim/clm_5D9D7F332E94, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5D9D7F332E94","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null},{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.med-dept.com/resources/ww2-medical-equipment-manufacturers-and-suppliers/","tier":"secondary","publisher":null,"published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_BCF468D9A07B","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson listed on: NYSE\", undated. Claim clm_BCF468D9A07B, https://asof.is/claim/clm_BCF468D9A07B, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_BCF468D9A07B","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_04E6B87CA267","predicate":"net_income","value":"26,804,000,000 United States dollar","valid_from":"2025-12-28","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 26,804,000,000 United States dollar\", as of 2025-12-28. Claim clm_04E6B87CA267, https://asof.is/claim/clm_04E6B87CA267, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_04E6B87CA267","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-11"}},{"id":"clm_BAB563999E2E","predicate":"operating_income","value":"21,590,000,000 United States dollar","valid_from":"2014-12-28","valid_to":null,"published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 21,590,000,000 United States dollar\", as of 2014-12-28. Claim clm_BAB563999E2E, https://asof.is/claim/clm_BAB563999E2E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_BAB563999E2E","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-24"}},{"id":"clm_DE9082D90894","predicate":"quarterly_net_income","value":"210,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 210,000,000 United States dollar\", as of 2026-09-27. Claim clm_DE9082D90894, https://asof.is/claim/clm_DE9082D90894, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_DE9082D90894","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_B42FC6E71EE6","predicate":"quarterly_operating_income","value":"5,827,000,000 United States dollar","valid_from":"2015-03-29","valid_to":null,"published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,827,000,000 United States dollar\", as of 2015-03-29. Claim clm_B42FC6E71EE6, https://asof.is/claim/clm_B42FC6E71EE6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_B42FC6E71EE6","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_0641FC210206","predicate":"quarterly_revenue","value":"25,399,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 25,399,000,000 United States dollar\", as of 2026-09-27. Claim clm_0641FC210206, https://asof.is/claim/clm_0641FC210206, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_0641FC210206","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_3F2BC974D10A","predicate":"registrant_name","value":"JOHNSON & JOHNSON","valid_from":"1996-01-23","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson registrant name: JOHNSON & JOHNSON\", as of 1996-01-23. Claim clm_3F2BC974D10A, https://asof.is/claim/clm_3F2BC974D10A, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_3F2BC974D10A","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_845673D0E6C8","predicate":"research_and_development","value":"109,000,000 United States dollar","valid_from":"2025-12-28","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 109,000,000 United States dollar\", as of 2025-12-28. Claim clm_845673D0E6C8, https://asof.is/claim/clm_845673D0E6C8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_845673D0E6C8","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-11"}},{"id":"clm_249E6427F083","predicate":"revenue","value":"94,193,000,000 United States dollar","valid_from":"2025-12-28","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 94,193,000,000 United States dollar\", as of 2025-12-28. Claim clm_249E6427F083, https://asof.is/claim/clm_249E6427F083, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_249E6427F083","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2025, filed 2026-02-11"}},{"id":"clm_7504E6D195B0","predicate":"shares_outstanding","value":"2,407,310,266 shares","valid_from":"2026-10-15","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,310,266 shares\", as of 2026-10-15. Claim clm_7504E6D195B0, https://asof.is/claim/clm_7504E6D195B0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_7504E6D195B0","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_94332C756B27","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_94332C756B27, https://asof.is/claim/clm_94332C756B27, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_94332C756B27","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_CF21B28C04B0","predicate":"state_of_incorporation","value":"NJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson state of incorporation: NJ\", undated. Claim clm_CF21B28C04B0, https://asof.is/claim/clm_CF21B28C04B0, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_CF21B28C04B0","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_AC3F2B6AB463","predicate":"ticker","value":"JNJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson ticker: JNJ\", undated. Claim clm_AC3F2B6AB463, https://asof.is/claim/clm_AC3F2B6AB463, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_AC3F2B6AB463","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_0B98C34873D9","predicate":"total_assets","value":"197,425,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 197,425,000,000 United States dollar\", as of 2026-09-27. Claim clm_0B98C34873D9, https://asof.is/claim/clm_0B98C34873D9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_0B98C34873D9","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_F6CBCD569325","predicate":"total_equity","value":"81,529,000,000 United States dollar","valid_from":"2026-09-27","valid_to":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 81,529,000,000 United States dollar\", as of 2026-09-27. Claim clm_F6CBCD569325, https://asof.is/claim/clm_F6CBCD569325, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_F6CBCD569325","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-10-21"}},{"id":"clm_E1C3F58B38A0","predicate":"website","value":"https://www.jnj.com","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson website: https://www.jnj.com\", undated. Claim clm_E1C3F58B38A0, https://asof.is/claim/clm_E1C3F58B38A0, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_E1C3F58B38A0","accessed":"2026-11-08"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"Johnson & Johnson: Changing health for humanity.","url":"https://www.jnj.com"}},{"id":"clm_3B23008B4919","predicate":"x_username","value":"JNJNews","valid_from":"2009-02-09","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson x username: JNJNews\", as of 2009-02-09. Claim clm_3B23008B4919, https://asof.is/claim/clm_3B23008B4919, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_3B23008B4919","accessed":"2026-11-08"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/JNJNews","url":"https://www.jnj.com"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}